Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 2
2017 3
2018 8
2019 6
2020 8
2021 8
2022 10
2023 5
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Interleukin-1 receptor accessory protein (IL-1RAP): A magic bullet candidate for immunotherapy of human malignancies.
Zarezadeh Mehrabadi A, Shahba F, Khorramdelazad H, Aghamohammadi N, Karimi M, Bagherzadeh K, Khoshmirsafa M, Massoumi R, Falak R. Zarezadeh Mehrabadi A, et al. Among authors: khoshmirsafa m. Crit Rev Oncol Hematol. 2024 Jan;193:104200. doi: 10.1016/j.critrevonc.2023.104200. Epub 2023 Nov 21. Crit Rev Oncol Hematol. 2024. PMID: 37981104 Review.
JAK Inhibition as a New Treatment Strategy for Patients with COVID-19.
Seif F, Aazami H, Khoshmirsafa M, Kamali M, Mohsenzadegan M, Pornour M, Mansouri D. Seif F, et al. Among authors: khoshmirsafa m. Int Arch Allergy Immunol. 2020;181(6):467-475. doi: 10.1159/000508247. Epub 2020 May 11. Int Arch Allergy Immunol. 2020. PMID: 32392562 Free PMC article. Review.
The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies.
Zalpoor H, Akbari A, Samei A, Forghaniesfidvajani R, Kamali M, Afzalnia A, Manshouri S, Heidari F, Pornour M, Khoshmirsafa M, Aazami H, Seif F. Zalpoor H, et al. Among authors: khoshmirsafa m. Cell Mol Biol Lett. 2022 Feb 2;27(1):10. doi: 10.1186/s11658-022-00311-1. Cell Mol Biol Lett. 2022. PMID: 35109786 Free PMC article. Review.
Oral Wheat Immunotherapy: Long-Term Follow-Up in Children with Wheat Anaphylaxis.
Babaie D, Ebisawa M, Soheili H, Ghasemi R, Zandieh F, Sahragard M, Seifi H, Fallahi M, Khoshmirsafa M, Darougar S, Mesdaghi M. Babaie D, et al. Among authors: khoshmirsafa m. Int Arch Allergy Immunol. 2022;183(3):306-314. doi: 10.1159/000519692. Epub 2021 Nov 16. Int Arch Allergy Immunol. 2022. PMID: 34784589
47 results